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Like most marine fish species studied so far, gilthead
seabream Sparus aurata L. have an essential requirement for
the polyunsaturated fatty acids (PUFA) eicosapentaenoic acid
(EPA, 20:5n-3), docosahexaenoic acid (DHA, 22:6n-3) and
arachidonic acid (ArA, 20:4n-6) to enable optimal growth and
survival. However, the desaturase and elongase activities
necessary to synthesize these long chain PUFA from shorter
carbon chain precursors are very low, so all three essential
PUFA have to be provided in the diet (Mourente and Tocher,
1994; Tocher and Ghioni, 1999; Bell and Sargent, 2003).
Dietary enrichment with ArA not only improved growth and
survival in larval seabream (Bessonart et al., 1999), but also
reduced the stress-related mortality that occurred after
handling and tank transfer (Koven et al., 2001). However,
higher levels of ArA (~6·mg·ArA·g–1·dry·mass in Artemia
nauplii) became detrimental when the larvae were under
conditions of chronic stress (Koven et al., 2003).
ArA is selectively incorporated into cellular phospholipids,
especially phosphatidylinositol, despite the general abundance
of n-3 PUFA in phospholipids of fish tissues (Linares and
Henderson, 1991). While the structural contribution of ArA to
the membrane appears to be limited, ArA can be rapidly
converted into eicosanoids, which can function as endocrine,
paracrine and/or autocrine modulators of secretory
mechanisms in various organs (Bihoreau et al., 1990; Lands,
1991). The conversion process begins when stress-related
triggers induce the release of ArA within 5–60·s by activating
phospholipases, mainly PLA2 (Axelrod et al., 1988; Smith,
1989; Buschbeck et al., 1999). It is often assumed that the
effects of dietary ArA on fish are mainly due to its function as
a precursor to these eicosanoids, particularly the prostaglandins
of the 2-series (Beckman and Mustafa, 1992; Bell et al., 1995;
Harel et al., 2001; Bell and Sargent, 2003). The prostaglandins
are known to control a wide variety of physiological processes
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In this study the influence of the dietary level of the
fatty acid arachidonic acid (ArA, 20:4n-6) was determined
on the acute stress response and osmoregulation of adult
gilthead seabream Sparus aurata L. Seabream were fed a
diet containing either 0.9% or 2.4% of total fatty acids as
ArA for 18 days before being subjected to a 5·min period
of net confinement. Prior to this stressor, a subgroup of
fish from both dietary treatment groups was treated with
acetylsalicylic acid (ASA), an irreversible blocker of cyclo-
oxygenase (COX). This would indicate whether any effects
were caused by an enhanced synthesis of prostaglandins
derived from ArA. The highest ArA levels were found in
the kidneys, and these were further enhanced by dietary
ArA-supplementation. In gill tissues, there were
significant changes in all selected fatty acid classes 24 h
after confinement, except for the docosahexaenoic acid
(DHA, 22:6n-3) : eicosapentaenoic acid (EPA, 20:5n-3)
ratio. ArA feeding strongly reduced the cortisol response
to confinement, which was partially counteracted by ASA
treatment. ArA also attenuated the stress-associated
increase in plasma osmolality and, in combination with
ASA, enhanced the osmolality and plasma chloride levels,
but reduced plasma sodium levels after confinement.
Furthermore, ArA enhanced the branchial Na+, K+-
ATPase activity both before and after confinement,
whereas feeding ASA diminished this effect. It appeared
that the effects of ArA-supplementation could not always
be ascribed to an increase in prostaglandin synthesis. It is
advisable to determine the long-term effects of replacing
fish oils in commercial diets with vegetable oils that
contain no long-chain fatty acids, particularly in
carnivorous/marine species with low fatty acid elongation
and desaturation activities. The effects of a low dietary
intake of ArA (and other polyunsaturated fatty acids)
should be studied over a longer term, taking into account
any consequences for the health of the fish.
Key words: acetylsalicylic acid, arachidonic acid, cyclooxygenase,
cortisol, eicosanoid, osmoregulation, prostaglandins, gilthead
seabream, Sparus aurata.
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in mammals as well as in fish, including respiratory and
cardiovascular output (McKenzie, 2001), ovulation and
spawning behavior, oocyte maturation, nervous system
function, osmoregulation (Mustafa and Srivastava, 1989) and
immune functions (Rowley et al., 1995). Furthermore,
prostaglandins can modulate the sensitivity of the
hypothalamus–pituitary–adrenal (HPA) axis in mammals at
various levels and alter the release of cortisol and
corticosterone in the stress response (Zacharieva et al., 1992;
Nye et al., 1997; Wang et al., 2000). In teleost fish the
release of cortisol is controlled by the analogous
hypothalamic–pituitary–interrenal (HPI) axis (Wendelaar
Bonga, 1997). Several studies have found indications that ArA,
and other PUFA, are involved in the regulation of cortisol
release in fish as well (Gupta et al., 1985; Wales, 1988; Harel
et al., 2001; Koven et al., 2003). Moreover, dietary
supplementation with ArA clearly reduced the cortisol
response of seabream larvae to air exposure (Van Anholt et al.,
2004).
The present study was designed to establish the influence of
the dietary level of ArA on the response of adult seabream to
an acute stressor. This could be relevant as attempts are being
made to replace fish oil by vegetable oils as a source of lipids
in the production of fish feeds. These oils contain no C20 and
C22 PUFA, which might lead to deficiencies, particularly in
marine fish that depend on a dietary source of these long-chain
fatty acids (Bell, 1998; Bell and Sargent, 2003). More
specifically, several studies have indicated that effects of
dietary ArA during the stress response could be attributed to
an increased production of the 2-series prostaglandins (see, for
instance, Gupta et al., 1985; Harel et al., 2001; Van Anholt et
al., 2003). Acetylsalicylic acid (ASA) is an irreversible blocker
of the COX pathway, which is responsible for the conversion
of ArA into prostaglandins (Smith, 1989). The administration
of ASA was an effective and stress-free method for the in vivo
inhibition of the COX pathway in Mozambique tilapia
Oreochromis mossambicus (Van Anholt et al., 2003).
Therefore, subgroups from each of the low- and high-ArA
treatments were fed ASA before being subjected to an acute
stressor to investigate the role ArA and prostaglandins in the
stress response.
Materials and methods
The experiments described in this study were conducted in
accordance with the current law on animal experimentation in
the Netherlands.
Fish
Male and female gilthead seabream Sparus aurata L. were
obtained from a commercial hatchery (Vendée Aquaculture,
La Faute sur Mer, France) at an approximate mass of 5·g. They
were raised in the laboratory of the University of Nijmegen
and fed commercial pellets for seabream and seabass (crude
protein 46%, total lipid 20%, ash 10%, water 5%; Filia LDX,
Trouvit, Fontaine Les Vervins, France) at 2% of their body
mass. The fatty acid profile of these pellets is listed in Table·1.
Fish were kept in recirculated synthetic saltwater (Aqua
Medic Sea Salt, Bissendorf, Germany) of 34‰ and 20°C with
a 12·h photoperiod. The recirculation system was equipped
with a protein skimmer, biological filter and UV-sterilizing
unit.
Experimental diets
Two types of 4·mm pelleted diets (The National Center for
Mariculture, Eilat, Israel) were used. These diets were identical
in their protein, lipid and micronutrient levels (crude protein
45%, total lipid 19%, ash 11% and water 8%), but differed in
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Table·1. Fatty acid profiles of the standard diet and the two experimental diets, the diet with a low level of arachidonic acid
(low-ArA) and pellets enriched with ArA (high-ArA)*
Diet Standard Low-ArA High-ArA
Saturates 29.4±0.1 30.3±0.3 30.2±0.3
Mono-unsaturates 36.1±0 33.1±0.1 32.7±0.3
Polyunsaturates 34.8±0.1 36.9±0.2 37.4±0.5
n-3 Polyunsaturates 27.9±0.1 22.5±0.3 20.7±0.6
n-6 Polyunsaturates 4.0±0.1 12.3±0.1 14.8±0
n-3/n-6 7.1±0.1 1.8±0 1.4±0
a -Linolenic acid (a -LNA,18:3n-3) 1.3±0.1 1.2±0 1.2±0
Linoleic acid (LA, 18:2n-6) 2.9±0 10.9±0.1 11.6±0
a -LNA/LA 0.4±0 0.1±0 0.1±0
Docosahexaenoic acid (DHA, 22:6n-3) 11.9±0.1 11.1±0.2 10.5±0
Eicosapentaenoic acid (EPA, 20:5n-3) 9.9±0 7.0±0.1 6.7±0
Arachidonic acid (ArA,20:4n-6) 0.6±0 0.9±0 2.4±0
DHA/EPA 1.2±0 1.6±0 1.6±0
DHA/ArA 20.7±1.1 12.5±0.3 4.3±0.1
EPA/ArA 17.3±0.6 7.8±0.1 2.7±0.1
*See Materials and methods. 
Fatty acids were determined in duplicate subsamples and are expressed as percentages of total fatty acids. Values are means ± S.E.M.
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their fatty acid composition. In the ‘low-ArA’ pellets, fish oil
(predominantly capelin oil) was incorporated at 10% of the
pellet dry mass, which contained moderate levels of DHA,
EPA and linoleic acid (LA), while having low levels of ArA.
In the other diet (high-ArA diet) 10% of the fish oil fraction
was replaced with ARASCO (Martek Biosciences, Columbia,
MD, USA) to give a final ArA level of 2.4±0.0% of total fatty
acids, compared to 0.9±0.0% of total fatty acids in the low-
ArA diet. This corresponded to 1.9·mg·ArA·g–1·dry·mass and
0.6·mg·ArA·g–1·dry·mass in the high- and low-ArA pellets,
respectively. ARASCO is a highly purified ArA-rich oil
extracted from the fungus Mortierella alpina, containing ~40%
ArA of total fatty acids. The fatty acid compositions of the
pellets were determined according to Koven et al. (2001) and
the results are listed in Table·1.
Experimental design and stress challenge
In two consecutive trials, 160 seabream (80.7±1.2·g) from
the same cohort were used. Each trial included 80 seabream,
which were equally divided according to mass into eight
groups of ten fish. Four groups of ten fish were fed low-ArA
containing pellets, while the other four groups were fed the
high-ArA containing pellets. All fish were fed daily rations of
2% of their body mass for a period of 18 days. At the end
of this period, two groups of ten fish from each treatment
group received three doses of ASA in 2 days
(100·mg·kg–1·body·mass, based on mean mass of the group).
ASA was incorporated into gelatin capsules together with
crushed pellets, which were eaten voluntarily within 5·min,
according to the method described by Van Anholt et al. (2003).
On the second day, approximately 4·h after receiving their last
meal or dose of ASA, several fish were sampled for baseline
values. Our previous observations in tilapia indicated that
plasma salicylate levels peaked around 5·h after administration
before declining to basal levels over a 15·h period (Van Anholt
et al., 2003). Confinement was therefore timed in such a way
that the fish would experience any stressor-induced peak in
plasma cortisol whilst plasma salicylate levels were still
increasing. As plasma salicylate measurements are corrected
for blank readings (<0.14·mmol·l–1), the salicylate in control
fish was probably of dietary origin such as vegetable material,
a known source of natural salicylates. The remaining fish were
immediately subjected to the stress challenge, which consisted
of 5·min of confinement in a submerged dip-net. After
confinement they were released back into the aquarium and
sampled after 20·min, 60·min or 24·h. Fish were anaesthetized
in a 2% 2-phenoxyethanol solution and blood samples were
immediately collected from the caudal vein using heparinized
needles. Plasma samples were collected after centrifugation
(16·000·g, 5·min) and stored at –20°C until analysis. Tissue
samples of gills, muscle and kidney were removed
immediately and stored at –30°C until analysis. Gill arches
were dissected and stored frozen in SEI buffer (300·mmol·l–1
sucrose, 20·mmol·l–1 Na2EDTA, 100·mmol·l–1 imidazole,
adjusted to pH·7.4 with Hepes-Tris) until analysis of Na+, K+-
ATPase activity.
Plasma measurements
Cortisol levels were determined using a competitive
radioimmunoassay (Campro Scientific, Veenendaal, The
Netherlands) according to the procedure described in Van
Anholt et al. (2003). Plasma glucose levels were determined in
duplicates with Sigma’s INFINITY glucose reagent according
to the manufacturer’s protocol (Sigma-Aldrich, Poole, Dorset,
UK). Plasma concentrations of lactate were assayed in
duplicate by a standard colorimetric assay (735-10; Sigma-
Aldrich). Plasma concentrations of sodium, potassium and
chloride were determined by flame photometry (Radiometer
FLM3, Copenhagen, Denmark) and plasma osmolality was
determined in 50·m l undiluted plasma samples using an
automatic cryoscopic osmometer (Osmomat 030, Gonotec,
Berlin, Germany).
Na+, K+-ATPase activity
Branchial filaments were collected and homogenized in
250·m l SEI buffer containing aprotinin (5·m l·ml–1), and after
centrifugation (10·min at 500·g) supernatants were used for
analysis. ATPase activity was determined as the specific
release of inorganic phosphate Pi from ATP, using either
12.5·mmol·l–1 KCl or 1·mmol·l–1 ouabain in the medium,
according to the method described in Van Anholt et al. (2003).
The difference between the total ATPase activity and the
ouabain-insensitive ATPase activity was designated as the
ouabain-sensitive, K+-dependent Na+, K+-ATPase activity and
expressed in m mol·Pi·h–1·mg–1·protein.
The in vitro effect of free ArA on Na+, K+-ATPase activity
Gill and kidney homogenates of eight control fish were
pooled and the COX inhibitor indomethacin (10·m g·ml–1
homogenate) was added to prevent prostaglandin synthesis.
The Na+, K+-ATPase activity was assayed using free ArA
in both incubation media, containing KCl or ouabain,
respectively. Stock solutions of free ArA (Sigma, St Louis, MI,
USA) were prepared in 100% methanol and 1003 diluted with
the reaction media to their final concentrations, 1–100·m mol·l–1
at 1% (v/v) methanol. Enzyme activity in the presence of added
ArA was expressed as a percentage of the value in the 1%
methanol controls.
Statistics
Initial analysis revealed no differences between the two
trials and the results were therefore combined and treated as
one experiment. All data are expressed as means ± S.E.M.
Levene’s Tests for homogeneity of variances indicated that
log-transformation was required for cortisol data and arcsine
transformations were performed on the percentage data of fatty
acids to achieve homogeneity of variance. Three-way analyses
of variance (ANOVAs) were performed to determine the
effects of the factors ArA feeding, ASA-administration and
time of sampling. Post hoc multiple comparison tests (Tukey’s
HSD) were used to determine which time points differed
significantly (SPSS software, version 11.5). Effects of free
ArA in the in vitro Na+, K+-ATPase test were compared
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with repeated-measures ANOVA against the activity at 1%
methanol. 5% level of probability was accepted as statistically
significant.
Results
No mortality was observed during the experiments, nor was
there any difference in growth between treatments at the end
of the feeding trials. During the 18 days of the feeding trial the
fish increased in mass from 80.7±1.2·g to 89.1±1.5·g (means
± S.E.M.). The gelatin capsules containing ASA were eaten
voluntarily within 5–10·min and did not reduce appetite when
fed simultaneously with the food pellets. Macroscopic
evaluation revealed no hemorrhages at the end of the
experiments.
ArA feeding had no effect on plasma salicylate levels.
Salicylate levels were significantly elevated in seabream that
received ASA (P<0.001; Table·2). In all four treatments
salicylate levels had dropped below those of all other time
points after 24·h (P<0.001). Furthermore, a significant
interaction existed between ASA administration and time of
sampling (P=0.013).
Fatty acid profiles of gill, kidney and muscle tissues prior to
net confinement (t=0) and 24·h after the stressor (t=24·h) are
listed in Table·3, and significant effects are presented in
Table·4. Feeding the ArA-supplemented diet for 18 days to
seabream significantly increased (P=0.028) the levels of ArA
in kidneys and reduced the level of linoleic acid (P=0.046), as
well as increased the saturated fatty acid levels (P=0.049). ArA
feeding decreased the DHA/ArA and EPA/ArA ratios in
kidneys (P<0.001), while reducing the DHA/ArA ratio in gill
tissues (P=0.035). In the gills, all major fatty acids were
significantly different 24·h after confinement, exhibiting either
increasing or declining percentages, except for the DHA/EPA
ratio (for details, see Table·4). At the same time the levels of
saturated fatty acids in the kidneys were significantly
(P=0.029) enhanced by confinement, where muscle tissues
exhibited a significant increase (P=0.042) in the DHA/EPA
ratio after 24·h. There were no significant interactions between
factors in any of tissues tested.
Within 20·min after confinement plasma cortisol levels
increased substantially in all treatments, resulting in
significantly higher plasma levels compared to all other time-
points (P<0.001; Fig.·1). After 60·min, cortisol levels were no
longer significantly elevated compared to the pre-confinement
levels. The ArA-supplemented seabream exhibited a
significantly lower cortisol response (P=0.012) compared to
the fish fed the ‘low-ArA’ diet. In addition, ASA significantly
affected the cortisol response (P=0.045). In the low-ArA fed
seabream cortisol levels were reduced by ASA, whereas in the
high-ArA fed fish cortisol levels were enhanced by ASA.
There were no significant interactions between ArA, ASA,
and/or the time of sampling.
The fish responded to confinement with a significant
increase (P<0.001) in plasma glucose at t=20·min, but glucose
was no longer significantly different from pre-confinement
levels after 60·min (Fig.·2). Glucose levels were significantly
influenced by the administration of ASA (P=0.015). Glucose
levels were markedly reduced after ASA administration in the
seabream fed the low-ArA diet, while glucose levels were not
influenced by ArA-supplementation, nor were there any
significant interactions between ArA, ASA, and/or time of
sampling.
Plasma lactate levels increased in all treatments 20·min after
confinement (P<0.001; Fig.·3). 1·h later, lactate levels were
still significantly higher than prior to confinement (P=0.029),
as well as at 20·min and 24·h afterwards (P=0.001 and 0.032,
respectively). The dietary level of ArA had no effect on plasma
lactate levels, whereas the administration of ASA significantly
(P=0.024) altered the lactate response, mainly in the high-ArA
fed seabream. This was also indicated by the significant
interaction between all three factors, ArA, ASA and time of
sampling (P=0.032).
Plasma osmolality increased considerably within 20·min in
all treatments (P<0.001), until at least 60·min (P=0.008), but
after 24·h these levels were no longer significantly different
from levels prior to confinement (Fig.·4). Plasma osmolality
was not affected by ArA-supplementation, but the effect of
ASA was significant (P=0.020). In the low-ArA group plasma
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Table·2. Plasma levels of salicylate in plasma of gilthead
seabream, after they were fed a diet low in arachidonic acid
(low-ArA) or a diet enriched with ArA (high-ArA)
Treatment* Time† (min) Salicylate ( m mol·l–1)
Low-ArA 0 116.5±9.9
20 118.9±15.0
60 103.5±20.5
24·h 13.8±12.0
Low-ArA+ASA 0 290.4±46.3
20 335.3±60.0
60 200.6±39.7
24·h 42.3±5.8
High-ArA 0 95.0±12.2
20 121.3±22.4
60 127.4±54.1
24·h 46.8±5.7
High-ArA+ASA 0 282.4±71.5
20 277.2±62.9
60 402.2±136.8
24·h 38.2±13.9
*Dietary ArA had no effect on salicylate levels, which were
significantly higher in seabream that received ASA (P<0.001).
†In all four treatments, plasma salicylate levels were significantly
lower after 24·h than at all other time points (P<0.001). The
interaction between ASA administration and time of sampling was
significant (P=0.013).
Fish were exposed to a stressor (5·min confinement in a dip-net)
and samples were collected just before (t=0) and at intervals after
confinement (20·min, 60·min, 24·h). The groups that were treated
with acetylsalicylic acid (+ ASA) were confined 4·h after the last
dose of 100·mg·ASA·kg–1·body·mass. 
Values are means ± S.E.M. of 10 fish.
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Table·3. Overview of (categories of) fatty acids expressed as percentages of total fatty acids of gill, kidney and muscle tissues
Low-ArA Low-ArA+ASA High-ArA High-ArA+ASA
0·h 24·h 0·h 24·h 0·h 24·h 0·h 24·h
(A) Gill 
Saturates 36.1±2.7 39.9±0.2 34.4±2.9 39.0±2.3 34.4±3.1 42.6±1.7 35.6±2.7 41.2±0.8
Mono-unsaturates 44.7±1.9 50.0±3.1 42.7±1.9 47.8±1.8 43.2±1.6 46.5±1.4 44.2±1.7 47.6±0.9
Polyunsaturates 19.4±4.6 9.9±0.8 23.0±4.4 13.3±3.9 22.6±4.7 10.9±1.7 20.4±4.4 11.3±1.7
n-3 Polyunsaturates 13.7±3.9 5.3±0.5 16.7±3.7 8.3±3.3 16.2±3.9 6.6±1.4 14.7±3.8 6.5±1.2
n-6 Polyunsaturates 3.7±0.5 3.1±0.2 4.6±0.5 3.6±0.6 4.6±0.6 2.9±0.2 4.1±0.6 3.3±0.5
n-3/n-6 3.4±0.6 1.7±0.1 3.6±0.6 2.1±0.4 3.3±0.4 2.2±0.4 3.4±0.4 1.9±0.1
a -LNA 0.6±0.1 0.4±0 0.8±0.2 0.4±0.1 0.7±0.1 0.3±0.1 0.6±0.1 0.4±0
LA 2.9±0.4 2.4±0.2 3.4±0.4 2.5±0.4 3.3±0.5 2.0±0.1 1.0±0.4 2.3±0.3
a -LNA/LA 0.2±0 0.2±0 0.2±0 0.2±0 0.2±0 0.2±0 0.2±0 0.2±0
DHA 7.1±2.2 2.8±0.4 7.9±2.1 4.2±1.7 8.1±2.0 2.8±0.8 7.8±2.0 3.3±0.7
EPA 3.4±1.0 1.3±0.1 4.6±1.1 2.1±0.9 4.1±1.0 2.4±0.9 3.7±0.9 1.5±0.3
ArA 0.5±0.1 0.4±0.1 0.6±0.1 0.5±0.1 0.8±0.1 0.5±0 0.7±0.1 0.6±0.1
DHA/EPA 2.1±0.1 2.2±0.1 1.8±0.3 2.0±0.1 2.0±0 1.8±0.4 2.1±0.1 2.2±0.1
DHA/ArA 13.5±2.1 7.4±0.3 13.3±2.4 7.8±1.7 10.0±1.1 6.1±1.5 11.3±0.7 6.0±0.3
EPA/ArA 6.4±0.9 3.4±0.2 8.9±3.0 4.0±0.9 5.0±0.6 4.8±1.6 5.4±0.4 2.8±0.1
(B) Kidney
Saturates 40.4±7.0 33.8±8.2 36.9±3.3 51.2±7.8 39.4±3.8 44.6±4.1 44.9±3.8 53.9±5.0
Mono-unsaturates 26.4±1.1 30.3±3.0 28.2±2.3 23.4±1.5 25.5±3.4 26.8±4.8 26.5±1.5 23.1±4.9
Polyunsaturates 33.4±5.8 36.0±8.8 35.0±2.2 25.8±6.5 35.2±2.8 29.1±5.1 28.8±3.5 23.1±1.2
n-3 Polyunsaturates 18.1±1.5 23.7±6.1 21.1±1.4 14.8±5.2 21.4±1.5 14.8±3.9 17.0±2.5 12.7±1.5
n-6 Polyunsaturates 13.2±3.8 10.2±2.3 11.4±0.8 8.8±1.5 12.0±1.2 11.8±1.2 9.9±1.1 8.7±0.6
n-3/n-6 1.5±0.3 2.3±0.1 1.9±0.1 1.6±0.4 1.8±0.1 1.2±0.3 1.7±0.2 1.5±0.2
a -LNA 0.6±0.1 0.8±0.2 0.6±0 0.6±0.2 0.7±0.3 0.4±0.1 0.7±0.3 0.5±0.1
LA 6.1±1.4 5.2±1.1 5.5±0.5 4.3±0.7 5.1±0.3 4.4±0.4 4.3±0.6 3.9±0.4
a -LNA/LA 0.1±0 0.2±0.1 0.1±0 0.1±0 0.1±0 0.1±0 0.1±0 0.1±0
DHA 11.5±1.1 15.3±4.1 13.3±1.0 9.4±3.5 13.9±1.0 9.8±2.7 11.1±1.6 7.1±1.3
EPA 4.0±0.2 5.4±1.6 4.9±0.3 3.3±1.1 4.6±0.4 3.0±0.8 3.8±0.4 3.1±0.1
ArA 3.1±1.1 2.8±0.8 2.6±0.3 2.0±0.5 4.6±0.4 3.6±0.5 3.2±0.7 3.1±0.4
DHA/EPA 2.9±0.1 2.9±0.1 2.7±0.1 2.8±0.3 3.1±0.1 3.3±0.1 2.9±0.2 2.3±0.4
DHA/ArA 4.4±1.1 5.8±0.4 5.2±0.3 4.2±0.9 3.1±0.2 2.6±0.6 3.6±0.4 2.4±0.5
EPA/ArA 1.5±0.5 2.0±0.1 1.9±0.1 1.5±0.3 1.0±0.1 0.8±0.2 1.3±0.1 1.1±0.2
(C) Muscle
Saturates 28.2±0.4 31.8±3.1 29.3±0.5 29.9±0.8 28.4±0.7 28.1±0.1 27.8±0.1 27.7±0.2
Mono-unsaturates 25.8±2.0 22.0±1.0 24.1±1.2 24.9±1.0 24.8±1.5 23.2±0.7 26.0±2.3 22.7±1.3
Polyunsaturates 46.3±1.7 46.5±3.0 46.9±1.3 45.5±1.2 47.1±1.0 49.0±0.8 46.5±2.2 49.7±1.2
n-3 Polyunsaturates 38.4±1.9 39.2±2.9 39.0±1.1 37.5±1.3 39.0±0.9 41.4±0.7 39.1±2.1 42.0±1.2
n-6 Polyunsaturates 6.2±0.3 6.0±0.4 6.6±0.3 6.5±0.4 6.5±0.1 6.0±0.1 5.8±0.2 6.4±0.6
n-3/n-6 6.2±0.5 6.6±0.4 6.0±0.2 5.8±0.4 6.0±0.2 6.9±0.1 6.8±0.3 6.8±0.7
a -LNA 0.6±0.1 0.6±0.1 0.6±0 0.7±0.1 0.6±0.1 0.4±0.1 0.6±0.1 0.5±0
LA 3.7±0.2 3.4±0.2 3.9±0.1 3.8±0.2 3.5±0.1 3.1±0.1 3.1±0.1 3.3±0.2
a -LNA/LA 0.2±0 0.2±0 0.2±0 0.2±0 0.2±0 0.1±0 0.2±0 0.1±0
DHA 25.2±2.1 26.7±2.5 25.7±1.0 24.5±1.3 25.6±1.1 28.2±0.5 25.7±2.2 28.9±1.4
EPA 8.3±0.2 8.1±0.4 9.0±0.3 8.2±0.3 8.6±0.2 8.8±0.2 8.6±0.2 8.7±0.1
ArA 1.5±0.2 1.6±0.2 1.8±0.2 1.8±0.3 2.0±0 1.9±0.1 1.7±0.2 2.1±0.2
DHA/EPA 3.0±0.2 3.3±0.2 2.9±0.1 3.0±0.2 3.0±0.2 3.2±0.1 3.0±0.2 3.3±0.2
DHA/ArA 17.0±1.4 17.4±0.9 15.0±1.5 15.0±1.8 12.9±0.3 15.1±0.5 15.6±0.9 14.0±1.6
EPA/ArA 5.8±0.6 5.4±0.4 5.4±0.7 5.0±0.5 4.3±0.2 4.7±0.2 5.4±0.6 4.3±0.5
Samples were taken at the end of the feeding period with either the ‘low-ArA’ or the ‘high-ArA’ diet, followed by treatment with
acetylsalicylic acid when indicated (+ ASA). Samples were collected just prior to (t=0·h) and 24·h after net confinement. 
Values represent means ± S.E.M. of 5 fish. Significant differences are shown in Table·4.
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osmolality was reduced, while in the high-ArA group plasma
osmolality was elevated by ASA. Furthermore, there was a
strong interaction between ArA and time of sampling
(P<0.001), as well as between ArA and ASA (P=0.023). The
interaction of ASA administration with time was also
significant (P=0.001).
Plasma sodium levels were markedly altered by confinement
(P<0.001), with a clear increase after 20·min (P=0.012),
followed by a decrease below pre-confinement levels after 24·h
in all treatments (P<0.001; Fig.·5A). Neither ArA nor ASA
had a significant effect on the sodium response when analyzed
as separate factors, yet the interaction between ArA and ASA
was significant (P=0.043).
In all treatments plasma chloride levels increased within
20·min after confinement (P<0.001) and remained
significantly elevated for at least 24·h compared to the levels
R. D. Van Anholt and others
Table·4. Three-way ANOVAs were performed on the arcsine transformed percentage data of the (categories of) fatty acids of the
three tissues presented in Table·3 
Gills Kidneys Muscles
ArA ASA Confinement ArA ASA Confinement ArA ASA Confinement
Saturates – – 0.002 0.049 – 0.029
Mono-unsaturates – – 0.002
Polyunsaturates – – <0.001
n-3 Polyunsaturates – – <0.001
n-6 Polyunsaturates – – 0.005
n-3/n-6 – – <0.001
a -LNA – – <0.001
LA – – 0.001 0.046 – – 0.001
a -LNA/LA – – 0.004
DHA – – 0
EPA – – 0.001
ArA – – 0.027 0.028
DHA/EPA – – – – – – – 0.042
DHA/ArA 0.035 – <0.001 <0.001
EPA/ArA – – 0.008 <0.001
Significant P values (P<0.05) of the three tested factors, dietary arachidonic acid (low-ArA vs high-ArA), acetylsalicylic acid treatment (no
ASA vs +ASA), and confinement (t=0 vs t=24·h), are listed.
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Fig.·1. The effect of a diet low in arachidonic acid (low-ArA) and an ArA-enriched diet (high-ArA) in combination with acetylsalicylic acid
(ASA) treatment on plasma cortisol responses to 5·min net confinement. Open circles, low-ArA; filled circles, low-ArA + ASA; open triangles,
high-ArA; filled triangles, high-ArA + ASA. Samples were taken from non-stressed fish (t=0) and at several intervals after confinement
(t=20·min, 60·min, 24·h). ASA-treated fish were subjected to confinement 4·h after the last dose of ASA. Each time point represents the mean
value ± S.E.M. of 10 fish. The results of both graphs were combined for analysis and significant effects of the factors: ArA supplementation,
ASA treatment, time after confinement, and/or interactions are indicated: *P<0.05, **P<0.01, ***P<0.001 (3-way ANOVA).
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prior to confinement (P=0.007; Fig.·5B). ArA-supplemented
seabream exhibited significantly higher (P<0.001) plasma
chloride levels compared to the fish fed the low-ArA diet.
In addition, plasma osmolality was significantly elevated
(P=0.017) in both dietary treatments after ASA treatment. No
significant interactions were found between any of the factors.
Confinement had a significant effect on plasma potassium
(P<0.001) with a significant decrease after 20·min (P=0.010)
in all treatments. Potassium levels remained lower than pre-
confinement levels for at least 24·h (P<0.001; Fig.·5C). ArA-
supplementation had no effect on plasma potassium levels,
whilst ASA administration resulted in significantly elevated
levels of potassium (P=0.041), mainly in the ArA-
supplemented seabream.
The branchial Na+, K+-ATPase activity was significantly
higher (P<0.001) in the ArA-supplemented fish than in the
low-ArA group. The ATPase activity was also markedly higher
24·h after confinement than prior to confinement (P=0.039;
Fig.·6). In addition, the interaction between ArA and time of
sampling was significant (P=0.041), while ASA had no
significant effect on the ATPase activity.
Free ArA in the incubation medium reduced the Na+, K+-
ATPase activity of gill homogenates in a dose-dependent way
(P=0.003), except at 10 and 30·m mol·l–1 ArA (Fig.·7).
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Fig.·2. The effect of ArA, ASA and net confinement on plasma glucose levels. Samples were taken from non-stressed fish (t=0) and at intervals
after confinement (t=20·min, 60·min, 24·h). Open circles, low-ArA; filled circles, low-ArA + ASA; open triangles, high-ArA; filled triangles,
high-ArA + ASA. ASA-treated fish were subjected to confinement 4·h after the last dose of ASA. Values are means ± S.E.M., N=10.
0
2.0
4.0
6.0
8.0
10.0
0
2.0
4.0
6.0
8.0
10.0
ASA *
Time ***
ArA×ASA×time *
Low ArA High ArA
Time (min)
0 20 40 60 0 20 40 60
[L
ac
tat
e] 
(m
mo
l l–
1 )
Time (min)
24 h24 h
Fig.·3. The effect of ArA, ASA and net confinement on plasma lactate levels. Samples were taken from non-stressed fish (t=0) and at intervals
after confinement (t=20·min, 60·min, and 24·h). Open circles, low-ArA; filled circles, low-ArA + ASA; open triangles, high-ArA; filled triangles,
high-ArA + ASA. ASA-treated fish were subjected to confinement 4·h after the last dose of ASA. Values are means ± S.E.M., N=10.
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Discussion
The incorporation of ArA into gills, intestine, muscle and
liver of gilthead seabream has been shown to be most efficient
below a dietary ArA level of 2% of total fatty acids, while it
dropped considerably above this level (Fountoulaki et al.,
2003). Hence, the ArA level of 2.4% of total fatty acids that
was used in our ‘high-ArA’ diet would have been sufficient to
enable satisfactory incorporation into the tissues. At the end of
the 18-day feeding period the kidneys of seabream fed the
ArA-supplemented diet had a significantly higher level of ArA,
which also reduced the DHA/ArA and EPA/ArA ratios in those
tissues. This relatively short feeding period did not alter the
ArA content of muscle and gill tissues. In these tissues the
DHA/ArA and EPA/ArA ratios were generally considerably
higher than the dietary ratios, signifying that DHA and EPA
were preferentially incorporated or retained over ArA. ArA is
deposited mainly into the polar lipids, especially at lower
dietary levels. Hence, the increase in ArA concentration in
kidney tissues apparently reflects changes in the polar lipid
fraction, which are more rapid than in the neutral lipid pool
(Linares and Henderson, 1991; Fountoulaki et al., 2003).
Changes in the fatty acid composition of fish muscle, on the
other hand, are thought to result from a dilution effect on
neutral lipid pools. This means that changes will result from
fatty acids being added to the existing stores as the fish grows
and more fatty acids are deposited (Jobling, 2003, 2004; Robin
et al., 2003). This process requires a substantial increase in
body mass, for which the feeding period in this study seems to
have been too short.
On subjecting the seabream to confinement to induce a stress
response, the fatty acid composition of the gills was affected,
but levels in muscle or kidney tissues hardly at all. After
confinement the levels of polyunsaturated fatty acids had
decreased in gill tissues, while the monounsaturated as well as
the saturated fatty acids exhibited an increase. These changes
were not only relative (in percentages of total fatty acids), but
were also accompanied by decreasing amounts of EPA, DHA
and ArA, when expressed in mg·g–1·dry·mass (data not shown).
When synthesizing new membranes, incorporation of readily
synthesized saturated and monounsaturated fatty acids is faster
than that of PUFA originating from the diet. Hence it is
possible that the changes in the gills reflect a higher rate of
turnover than in kidneys and muscle. The observed changes
might also arise from b -oxidation of the long-chain fatty acids.
However, this does not correspond to the general preference in
fish tissues for oxidation of monounsaturated fatty acids over
saturated fatty acids, which in turn are preferred over
polyunsaturated fatty acids (McKenzie et al., 2000).
Feeding the ArA-supplemented diet to gilthead seabream for
18 days was sufficient to substantially diminish the cortisol
response after net confinement, compared to the fish fed a diet
containing a low level of this fatty acid. This blunted response
to stress was very similar to what was found in seabream larvae
exposed to another type of acute stress. Both 28- and 50 days
post-hatch larvae showed considerable lower peak cortisol levels
when they were fed ArA-enriched Artemia nauplii prior to a
brief exposure to air (Van Anholt et al., 2004). These
observations in seabream are in complete contrast to the
augmented cortisol response observed in tilapia Oreochromis
mossambicus, when fed the same diet enriched with ArA
(R.D.V.A., F.A.T.S., W.M.K. and S.E.W.B., submitted).
Tilapia, like most freshwater species, can convert linoleic acid
into ArA, while gilthead seabream has a low ability to form ArA
from its precursor. Gilthead seabream apparently became more
sensitive to an acute stressor when the dietary intake of ArA was
low, emphasizing the importance of ArA in this respect.
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Fig.·4. Changes in plasma osmolality after feeding different diets and ASA administration. Samples were taken just prior to (t=0) and at intervals
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To determine whether the observed effects of ArA could be
contributed to an enhanced production of prostaglandins, the
COX-inhibiting ability of ASA was utilized. A previous study
on tilapia verified that the effect of ASA in fish was similar to
that in humans, as ASA inhibited the COX activity of kidney
homogenates and reduced plasma levels of prostaglandin E2
(PGE2; Van Anholt et al., 2003). Feeding the ASA-containing
capsules resulted in an almost threefold increase of the plasma
salicylate levels in our seabream and the low basal levels of
cortisol at the start of the tests confirmed that this was a stress-
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free method to administer ASA. This ASA treatment also
attenuated the confinement-induced cortisol response in the
seabream fed the low-ArA diet, which would indicate that
prostaglandins stimulated the release of cortisol at a low
dietary intake of ArA. However, this would not correspond to
the observed blunted cortisol response observed in seabream
with a high dietary intake of ArA, which would have resulted
in an elevated release of prostaglandins during stress. In fact,
administration of ASA caused a slight elevation of the cortisol
levels in those seabream that were supplemented with ArA in
advance. This argues against the assumption that ArA-
mediated effects can be attributed to the formation of COX-
derived metabolites.
It is possible that in this study the inhibition of the COX
pathway by ASA increased the availability of free ArA
immediately after confinement for the alternative pathways in
certain tissues. Eicosanoids resulting from conversion of ArA
by lipoxygenase and epoxygenase have been shown to
stimulate the release of ACTH and b -endorphin from the
pituitary, as well as to modify the induced release of cortisol
from the adrenals (Hirai et al., 1985). The available
information on the functions of other eicosanoids besides
prostaglandins in the control of the HPI axis of fish is very
limited and it remains to be determined how ArA is exactly
involved in this process.
Acute stress is normally associated with the release of
catecholamines that promote glycogenolysis in the liver cells
of fish, causing a rapid increase of plasma glucose levels
(Wendelaar Bonga, 1997). The accumulation of lactate during
stress either points to reduced uptake by liver cells for
gluconeogenesis or to the incomplete oxidation of glucose,
resulting from insufficient oxygen supply (Vijayan and Moon,
1992; Vijayan et al., 1997; Wendelaar Bonga, 1997; Fabbri et
al., 1998). In the present study the dietary level of ArA had no
effect on the basal levels of plasma glucose or lactate, nor
did it affect the confinement-induced hyperglycemia and
lactacidemia, suggesting that the catecholamine release was
not affected. Nevertheless, the treatment with ASA reduced the
basal glucose levels in the ‘low-ArA’-fed fish, whereas ASA
had no effect on the fish fed the ArA-supplemented diet. The
lactate levels were affected in a different way by ASA. ASA
delayed the recovery to basal levels in the low-ArA group, and
augmented the lactate response in the ArA-supplemented
seabream. Though it is unclear which processes were altered
by the change in the dietary ArA intake, some suggestions can
be made. For instance, the low ratio of n-3/n-6 PUFA might
have enhanced the metabolic rate and oxygen demand, as
suggested by McKenzie et al. (2000) and McKenzie (2001).
On the other hand, free ArA has been shown to change the
binding of catecholamines or corticosteroids to their receptors
in liver cells (Vallette et al., 1991; Lee and Struve, 1992;
Skalski et al., 2001), which could have reduced hepatic
gluconeogenesis causing elevated lactate levels in the
seabream in the present study.
Acute stress and the associated release of catecholamines
can lead to an increased permeability of the branchial
epithelium, leading to an influx of ions in fish in a
hyperosmotic environment. This in turn stimulates the ionic
extrusion by the chloride cells, located mainly in the opercula
and gills (Wendelaar Bonga, 1997; McCormick, 2001). In
seabream from both dietary treatments, plasma sodium and
chloride levels increased within 20·min after confinement in a
similar way, indicating an increased permeability. The
immediate decrease in plasma potassium in all treatments was
more likely caused by the enhanced uptake of K+ into red blood
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cells, in reaction to the low plasma oxygen levels associated
with acute stress (Gibson et al., 2000). ArA supplementation
attenuated the stressor-induced increase in plasma osmolality.
The plasma levels of sodium and chloride did not exhibit a
corresponding increase, suggesting the presence of other
factors that influence the osmolality. Interestingly, ASA
treatment appeared to counteract the effect of ArA and resulted
in an increase in plasma osmolality after 1·h. Furthermore, both
plasma chloride and potassium levels were enhanced by ASA
in the ArA-supplemented seabream. This suggested a possible
increase in the permeability of the membranes due to the
combination of ASA and ArA. However, the confinement-
induced increase in sodium was attenuated by ASA in that
same group, arguing against an enhanced influx of ions.
Cortisol has been shown to stimulate the proliferation of
branchial chloride cells and to increase the activity of ion-
transporting enzymes, particularly Na+, K+-ATPase, the major
driving force for branchial transepithelial ion transport located
in the chloride cells (Wendelaar Bonga, 1997). Indeed, the
branchial Na+, K+-ATPase activity had increased in both
dietary treatments 24·h after confinement. In addition, the ArA-
supplemented seabream showed a distinctly higher branchial
Na+, K+-ATPase activity already prior to confinement.
Although the effect of ASA treatment was not significant, the
ArA-supplemented fish exhibited no increase in the ATPase
activity when treated with ASA. From these results it is not
clear whether ArA-derived prostaglandins were involved in the
regulation of the branchial Na+, K+-ATPase. However, it
also appears unlikely that the stimulating effect of ArA
supplementation on the ATPase activity could be contributed
to ArA itself, as the tests showed that free ArA was an inhibitor
of the branchial ATPase activity in vitro. Inhibitory effects of
unsaturated fatty acids on Na+, K+-ATPases have been
demonstrated in vitro before, and were attributed to a decreased
enzyme affinity for extracellular K+ due to direct interactions
of the fatty acids with sodium-pump protein subunits (Swann,
1984; Swarts et al., 1990; Haag et al., 2001). Alternatively,
ArA might have stimulated the Na+, K+-ATPase activity in
gills by enhancing the release of osmoregulatory hormones
such as prolactin and thyroxin (Kolesnick et al., 1984a,b;
Mustafa and Srivastava, 1989).
In this study we have demonstrated marked changes in the
stress response due to feeding different dietary levels of ArA
for 18 days, which emphasizes the physiological impact that a
relatively small change in a single dietary fatty acid can have.
Providing optimal ArA levels in commercial diets for marine
species could be effective in moderating the stress response
and improving survival following exposure to handling and
transport, as routinely occurs during the grow-out of fish in
aquaculture. Furthermore, replacing fish oils in commercial
diets with vegetable oils that contain no C20 and C22 PUFA,
combined with the low fatty acid elongation and desaturation
activities of carnivorous/marine species, will result in reduced
tissue levels of ArA, EPA and DHA (Bell, 1998; Bell and
Sargent, 2003; Montero et al., 2003). It is advisable to
determine the effects of such a low dietary intake of ArA and
other PUFA on a longer term, focussing not only on growth
performance and feed efficiency, but also on possible health
effects.
List of abbreviations
ASA acetylsalicylic acid
COX cyclo-oxygenase
ArA arachidonic acid (20:4n-6)
DHA docosahexaenoic acid (22:6n-3)
EPA eicosapentaenoic acid (20:5n-3)
PUFA polyunsaturated fatty acids
PL phospholipase
HPA hypothalamus–pituitary–adrenal
HPI hypothalamic–pituitary–interrenal
LA linoleic acid
Pi inorganic phosphate
PGE2 prostaglandin E2
a -LNA a -linolenic acid
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